Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

HIV pill Truvada shows more promise against infection
July 22, 2014

Several concerns about a prescription drug used to prevent HIV infection in people at high risk are being put to rest by the results of new research. Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses.

HIV pills show more promise to prevent infection
July 22, 2014

There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses.

Is Truvada, the pill to prevent H.I.V., 99 percent effective? Don’t be so sure
July 22, 2014

Truvada, the once-a-day pill to help keep people from contracting H.I.V., is on the cover of this week’s New York magazine, discussing how the pill is changing sex by drastically reducing gay men’s fear of infection.

Next generation: biological pacemakers
July 21, 2014

Direct reprogramming of cardiac muscle cells into pacemaker cells gives pig hearts back their rhythm.

Transplanting new brain cells into Alzheimer's patients could reverse memory loss
July 18, 2014

A new study by U.S. scientists revealed a way to alleviate the learning and memory deficits caused by a gene linked to Alzheimer's disease. By transplanting new cells into the brain, they saw improved brain activity, restoring cognition to normal levels in elderly mice. 

Memory and learning deficits restored in Alzheimer's mouse models
July 16, 2014

With more than 5 million Americans living with Alzheimer's disease, the race is on to develop new treatments for the condition. Now, researchers from the Gladstone Institutes in San Francisco, CA, and the University of California-San Francisco reveal they have successfully reversed learning and memory deficits in mouse models of Alzheimer's through transplantation of healthy brain cells.

Chemicals wake up dormant HIV
June 18, 2014

Compounds that boost the 'noise' in genetic activity of HIV can reactivate the latent virus. Such drugs could make it easier to stamp out quiescent HIV infections.

Reactivating latent HIV makes it an easier target
June 12, 2014

Bumping up the random "noise" associated with HIV gene expression can help reactivate the virus in cells where it has been latent, making it easier to find and kill, according to research from San Francisco Gladstone Institutes.

A ‘vaccine’ for heart disease could mean no pills, lettuce or a gym
June 12, 2014

It’s the latest in gene therapy, and it’s lowered cholesterol and heart attacks in mice. People are next.

Researchers at the Gladstone Institutes find novel approach to reactivate latent HIV
June 10, 2014

Findings published yesterday in the journal Science by a team of scientists at the Gladstone Institutes identified a new way to make latent HIV reveal itself, which could help overcome one of the biggest obstacles to finding a cure for HIV infection. The scientists discovered that increasing the random activity, or noise, associated with HIV gene expression—without increasing the average level of gene expression—can reactivate latent HIV.